Abstract
The aim of current immunotherapeutic approaches is to elicit an individual's immune response towards a tumor tissue to eliminate or, at least, to control proliferation of the neoplastic tumor cells. Among the contemporary cancer treatment strategies, the adoptive T cell transfer shows to be the most progressively developing method that uses an ex vivo modified and expanded tumor-specific T cells as a tool to target and destroy the neoplastic tumor cells.